Cargando…

Stability of peripheral blood immune markers in patients with asthma

BACKGROUND: Asthma is a complex disease with variable course. Efforts to identify biomarkers to predict asthma severity, the course of disease and response to treatment have not been very successful so far. We have previous suggested that PAR-2 and CRTh2 expression on specific peripheral blood cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha Palikhe, Nami, Bosonea, Ana-Maria, Laratta, Cheryl, Gandhi, Vivek Dipak, Nahirney, Drew, Hillaby, Angela, Bowen, Miranda, Bhutani, Mohit, Mayers, Irvin, Cameron, Lisa, Vliagoftis, Harissios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489239/
https://www.ncbi.nlm.nih.gov/pubmed/31168305
http://dx.doi.org/10.1186/s13223-019-0343-4
_version_ 1783414782067474432
author Shrestha Palikhe, Nami
Bosonea, Ana-Maria
Laratta, Cheryl
Gandhi, Vivek Dipak
Nahirney, Drew
Hillaby, Angela
Bowen, Miranda
Bhutani, Mohit
Mayers, Irvin
Cameron, Lisa
Vliagoftis, Harissios
author_facet Shrestha Palikhe, Nami
Bosonea, Ana-Maria
Laratta, Cheryl
Gandhi, Vivek Dipak
Nahirney, Drew
Hillaby, Angela
Bowen, Miranda
Bhutani, Mohit
Mayers, Irvin
Cameron, Lisa
Vliagoftis, Harissios
author_sort Shrestha Palikhe, Nami
collection PubMed
description BACKGROUND: Asthma is a complex disease with variable course. Efforts to identify biomarkers to predict asthma severity, the course of disease and response to treatment have not been very successful so far. We have previous suggested that PAR-2 and CRTh2 expression on specific peripheral blood cell subtypes may be biomarkers of asthma severity. We reasoned that parameters that remain stable when asthma symptoms are controlled would be the most appropriate to evaluate for their utility to predict loss of asthma control and/or severity of the disease. METHODS: Nineteen stable asthmatics were recruited from the University of Alberta Asthma clinic and followed in clinic every 3 months for a total of 4 visits. Patients had spirometry and completed the ACQ questionnaire in every visit. Blood was drawn in every visit and analyzed for a number of immune parameters by flow cytometry. These parameters included PAR-2 and CRTh2 expression on monocyte subgroups and T lymphocytes respectively, as well as numbers of eosinophils, innate lymphoid type-2 cells (ILC2) and dendritic cells. Within person stability of immune and physiological parameters was calculated using the intraclass correlation (ICC) using R version 3.4.0. RESULTS: FEV(1) (% predicted), FEV(1)/FVC ratio, ACQ5 and ACQ7 did not differ significantly over the 4 visits, as would be expected for patients with stable asthma. Peripheral blood eosinophil numbers by Kimura stain and by flow cytometry showed ICC scores of 0.44 and 0.52 respectively, indicating moderate stability. The % of ILC2 cells in peripheral blood also showed moderate stability [ICC score of 0.45 (0.14–0.67)]. The stability for all other immune parameters was poor. CONCLUSION: Among the peripheral blood immune parameters we studied, only numbers of eosinophils and ILC2 in peripheral blood were moderately stable over a year in stable asthmatics. Further studies are required to understand the reasons for the variability of the other cell types.
format Online
Article
Text
id pubmed-6489239
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64892392019-06-05 Stability of peripheral blood immune markers in patients with asthma Shrestha Palikhe, Nami Bosonea, Ana-Maria Laratta, Cheryl Gandhi, Vivek Dipak Nahirney, Drew Hillaby, Angela Bowen, Miranda Bhutani, Mohit Mayers, Irvin Cameron, Lisa Vliagoftis, Harissios Allergy Asthma Clin Immunol Research BACKGROUND: Asthma is a complex disease with variable course. Efforts to identify biomarkers to predict asthma severity, the course of disease and response to treatment have not been very successful so far. We have previous suggested that PAR-2 and CRTh2 expression on specific peripheral blood cell subtypes may be biomarkers of asthma severity. We reasoned that parameters that remain stable when asthma symptoms are controlled would be the most appropriate to evaluate for their utility to predict loss of asthma control and/or severity of the disease. METHODS: Nineteen stable asthmatics were recruited from the University of Alberta Asthma clinic and followed in clinic every 3 months for a total of 4 visits. Patients had spirometry and completed the ACQ questionnaire in every visit. Blood was drawn in every visit and analyzed for a number of immune parameters by flow cytometry. These parameters included PAR-2 and CRTh2 expression on monocyte subgroups and T lymphocytes respectively, as well as numbers of eosinophils, innate lymphoid type-2 cells (ILC2) and dendritic cells. Within person stability of immune and physiological parameters was calculated using the intraclass correlation (ICC) using R version 3.4.0. RESULTS: FEV(1) (% predicted), FEV(1)/FVC ratio, ACQ5 and ACQ7 did not differ significantly over the 4 visits, as would be expected for patients with stable asthma. Peripheral blood eosinophil numbers by Kimura stain and by flow cytometry showed ICC scores of 0.44 and 0.52 respectively, indicating moderate stability. The % of ILC2 cells in peripheral blood also showed moderate stability [ICC score of 0.45 (0.14–0.67)]. The stability for all other immune parameters was poor. CONCLUSION: Among the peripheral blood immune parameters we studied, only numbers of eosinophils and ILC2 in peripheral blood were moderately stable over a year in stable asthmatics. Further studies are required to understand the reasons for the variability of the other cell types. BioMed Central 2019-04-29 /pmc/articles/PMC6489239/ /pubmed/31168305 http://dx.doi.org/10.1186/s13223-019-0343-4 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Shrestha Palikhe, Nami
Bosonea, Ana-Maria
Laratta, Cheryl
Gandhi, Vivek Dipak
Nahirney, Drew
Hillaby, Angela
Bowen, Miranda
Bhutani, Mohit
Mayers, Irvin
Cameron, Lisa
Vliagoftis, Harissios
Stability of peripheral blood immune markers in patients with asthma
title Stability of peripheral blood immune markers in patients with asthma
title_full Stability of peripheral blood immune markers in patients with asthma
title_fullStr Stability of peripheral blood immune markers in patients with asthma
title_full_unstemmed Stability of peripheral blood immune markers in patients with asthma
title_short Stability of peripheral blood immune markers in patients with asthma
title_sort stability of peripheral blood immune markers in patients with asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489239/
https://www.ncbi.nlm.nih.gov/pubmed/31168305
http://dx.doi.org/10.1186/s13223-019-0343-4
work_keys_str_mv AT shresthapalikhenami stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT bosoneaanamaria stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT larattacheryl stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT gandhivivekdipak stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT nahirneydrew stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT hillabyangela stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT bowenmiranda stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT bhutanimohit stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT mayersirvin stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT cameronlisa stabilityofperipheralbloodimmunemarkersinpatientswithasthma
AT vliagoftisharissios stabilityofperipheralbloodimmunemarkersinpatientswithasthma